MDMA

Madrigal Mental Care Develops Psychedelic Drug Treatment for Post-Traumatic Stress Disorder

Novel Nasal-Spray Nano-Formulation Enables Nose-To-Brain Delivery of Biodegradable Nanoparticles that can Encapsulate Psychedelic Substances such as Psilocybin Madrigal Mental Care, a biopharmaceutical company developing a breakthrough delivery system for psychedelic drugs, introduced its novel nanotechnology for the treatment and prevention of post-traumatic stress disorder (PTSD) at Biomed Israel 2022, the premier international Life Science and …

Madrigal Mental Care Develops Psychedelic Drug Treatment for Post-Traumatic Stress Disorder Read More »

LSD: A Future Anti-Anxiety Pill?

New Study by Dr. Gabriella Gobbi Reveals the Neurobiological Mechanisms by which LSD could Relieve Anxiety The craze for psychedelics used for therapeutic purposes is real. However, the scientific evidence supporting their effectiveness and explaining their mode of action in treating mental health disorders is still very thin. A new study led by Dr. Gabriella …

LSD: A Future Anti-Anxiety Pill? Read More »

Using psychedelics for terminal illness and end of life

Death is the one thing all humans have in common, and everyone deserves to end their lives with dignity. There are several physical, mental, and emotional symptoms those at the end of life can face depending on their condition: pain, dyspnea (shortness of breath), mental confusion or delirium, agitation (also known as terminal restlessness), and …

Using psychedelics for terminal illness and end of life Read More »

World’s First Global Research Institute for Psychedelic Therapies Opens Its Doors

A global team of researchers have launched a first-of-its-kind research institute that will develop psychedelic medicines to treat mental health disorders and other medical conditions. The network is headquartered in Melbourne, Australia, and is supported with a planned investment of at least A$40 million dollars over five years. The newly launched Psychae Institute is the world’s first collaborative …

World’s First Global Research Institute for Psychedelic Therapies Opens Its Doors Read More »

Harvard Law’s Petrie-Flom Center Announces Project on Psychedelics Law and Regulation

The Project on Psychedelics Law and Regulation Seeks to Advance Evidence-Based Psychedelics Law and Policy The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School has announced a new research initiative, the Project on Psychedelics Law and Regulation (POPLAR). This three-year project will promote safety, innovation, and equity in psychedelics research, commerce, and …

Harvard Law’s Petrie-Flom Center Announces Project on Psychedelics Law and Regulation Read More »

New UCSF Research Program to Advance Psychedelics Research and Treatments

Psychedelics research in support of brain health is getting a major boost this month with the formation of the Neuroscape Psychedelics Division at the University of California, San Francisco (UCSF). Through $6.4M in private funding, the new division will take a unique translational research approach to integrate cutting-edge neuroscience technology with psychedelics treatment, including through …

New UCSF Research Program to Advance Psychedelics Research and Treatments Read More »

Psychedelic Science Holds Promise for Mainstream Medicine

UNLV Neuroscientists’ Work on Brain Activity Recently Published by Nature: Scientific Reports Psychedelic healing may sound like a fad from the Woodstock era, but it’s a field of study that’s gaining traction in the medical community as an effective treatment option for a growing number of mental health conditions. While the study of psychedelics as medicine …

Psychedelic Science Holds Promise for Mainstream Medicine Read More »

The Potential for Psychedelic Treatment for Veterans

From the fallout of COVID-19 to therapy becoming more accepted and recognized and the rise of new treatments, mental health has become a mainstream conversation. But one subset with specific needs remains neglected: Veterans. Veterans Lack Support When Returning Home From Deployment Havn Life Director and Veteran Tim Laidler was deployed to Afghanistan in 2008. …

The Potential for Psychedelic Treatment for Veterans Read More »

Hundreds of Canadians Already Struggling With Mental Health Conditions Plead for Access to Psychedelic Medicine

ATMA and SYNTAC Institute Collaborate to Submit a Group Application for Section 56 Exemption from Health Canada to Access Psychedelic Therapy ATMA Journey Centers Inc. (ATMA), an Alberta-based company focused on delivering innovative psychedelic-assisted therapies internationally, announced today that it has submitted a Group Application for Section 56 Exemption to Health Canada on behalf of Canadians …

Hundreds of Canadians Already Struggling With Mental Health Conditions Plead for Access to Psychedelic Medicine Read More »

Scroll to Top